122 related articles for article (PubMed ID: 31966362)
1. Reduced serum miR-138 is associated with poor prognosis of head and neck squamous cell carcinoma.
Bao L; Miao W; Yu Y
Int J Clin Exp Pathol; 2017; 10(10):10276-10281. PubMed ID: 31966362
[TBL] [Abstract][Full Text] [Related]
2. MiR-31 is a potential biomarker for diagnosis of head and neck squamous cell carcinoma.
Wang LL; Li HX; Yang YY; Su YL; Lian JS; Li T; Xu J; Wang XN; Jin N; Liu XF
Int J Clin Exp Pathol; 2018; 11(9):4339-4345. PubMed ID: 31949830
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.
Summerer I; Unger K; Braselmann H; Schuettrumpf L; Maihoefer C; Baumeister P; Kirchner T; Niyazi M; Sage E; Specht HM; Multhoff G; Moertl S; Belka C; Zitzelsberger H
Br J Cancer; 2015 Jun; 113(1):76-82. PubMed ID: 26057452
[TBL] [Abstract][Full Text] [Related]
5. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
[TBL] [Abstract][Full Text] [Related]
6. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
7. Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.
Lerner C; Wemmert S; Bochen F; Kulas P; Linxweiler M; Hasenfus A; Heinzelmann J; Leidinger P; Backes C; Meese E; Urbschat S; Schick B
J Cancer Res Clin Oncol; 2016 Apr; 142(4):757-66. PubMed ID: 26621153
[TBL] [Abstract][Full Text] [Related]
8. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
[TBL] [Abstract][Full Text] [Related]
9. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs modulating glycolysis as non-invasive prognostic biomarkers of HNSCC.
Avilés-Jurado FX; Muñoz C; Meler C; Flores JC; Gumà J; Benaiges E; Mora J; Camacho M; León X; Vilaseca I; Terra X
Eur Arch Otorhinolaryngol; 2021 May; 278(5):1585-1594. PubMed ID: 32737645
[TBL] [Abstract][Full Text] [Related]
12. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-381 is associated with poor prognosis in papillary thyroid carcinoma.
Huang T; Yi D; Xu L; Bu E; Zhu C; Sang J; Zhang Y
Int J Clin Exp Pathol; 2017; 10(12):11610-11616. PubMed ID: 31966518
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Wang F; Ying H; He B; Pan Y; Sun H; Wang S
Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
[TBL] [Abstract][Full Text] [Related]
16. Unpredictable changes of selected miRNA in expression profile of HNSCC.
Lamperska KM; Kozlowski P; Kolenda T; Teresiak A; Blizniak R; Przybyla W; Masternak MM; Golusinski P; Golusinski W
Cancer Biomark; 2016; 16(1):55-64. PubMed ID: 26484611
[TBL] [Abstract][Full Text] [Related]
17. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation and downregulation of miR-23b-3p are associated with upregulated PLAU: a diagnostic and prognostic biomarker in head and neck squamous cell carcinoma.
Huo Z; Li X; Zhou J; Fan Y; Wang Z; Zhang Z
Cancer Cell Int; 2021 Oct; 21(1):564. PubMed ID: 34702271
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Jamali Z; Asl Aminabadi N; Attaran R; Pournagiazar F; Ghertasi Oskouei S; Ahmadpour F
Oral Oncol; 2015 Apr; 51(4):321-31. PubMed ID: 25677760
[TBL] [Abstract][Full Text] [Related]
20. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
Pang PC; Shi XY; Huang WL; Sun K
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3765-3769. PubMed ID: 27735043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]